LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 65.12 | 17.25 | 2 | 5095 | 0.0004 | -0.2309 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 65.12 | 17.25 | 1518 | 5095 | 0.2979 | 0.7256 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 65.12 | 17.25 | 86 | 5095 | 0.0169 | 0.2162 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 65.12 | 17.25 | 1779 | 5095 | 0.3492 | 0.7593 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.09 | 17.25 | 2 | 5221 | 0.0004 | -0.2301 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.09 | 17.25 | 1593 | 5221 | 0.3051 | 0.7317 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.09 | 17.25 | 75 | 5221 | 0.0144 | 0.1952 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.09 | 17.25 | 1832 | 5221 | 0.3509 | 0.7613 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 69.06 | 17.25 | 2 | 5242 | 0.0004 | -0.2299 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 69.06 | 17.25 | 1637 | 5242 | 0.3123 | 0.7368 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 69.06 | 17.25 | 96 | 5242 | 0.0183 | 0.2314 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 69.06 | 17.25 | 1921 | 5242 | 0.3664 | 0.7708 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 71.03 | 17.25 | 2 | 5367 | 0.0004 | -0.2291 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 71.03 | 17.25 | 1687 | 5367 | 0.3143 | 0.7392 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 71.03 | 17.25 | 79 | 5367 | 0.0147 | 0.2017 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 71.03 | 17.25 | 1957 | 5367 | 0.3646 | 0.7706 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 73.00 | 17.25 | 3 | 5546 | 0.0005 | -0.1894 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 73.00 | 17.25 | 1747 | 5546 | 0.3150 | 0.7410 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 73.00 | 17.25 | 81 | 5546 | 0.0146 | 0.2040 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 73.00 | 17.25 | 2030 | 5546 | 0.3660 | 0.7726 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 74.97 | 17.25 | 1 | 5618 | 0.0002 | -0.2891 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 74.97 | 17.25 | 1786 | 5618 | 0.3179 | 0.7434 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 74.97 | 17.25 | 76 | 5618 | 0.0135 | 0.1944 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 74.97 | 17.25 | 2096 | 5618 | 0.3730 | 0.7772 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 76.94 | 17.25 | 3 | 5681 | 0.0005 | -0.1887 | MN20160310_N02 | C15 |